Key points are not available for this paper at this time.
Myocardial ECV (bolus or infusion technique) and pre-contrast T1 are biomarkers for cardiac AL amyloid and they predict mortality in systemic amyloidosis.
Banypersad et al. (Sun,) studied this question.